The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits (Q39758341)

14 September 2017

title

The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits (English)

1 reference

14 September 2017

1 reference

J M Witkin

1

1 reference

14 September 2017

J A Monn

2

1 reference

14 September 2017

D D Schoepp

3

1 reference

14 September 2017

X Li

4

1 reference

14 September 2017

C Overshiner

5

1 reference

14 September 2017

S N Mitchell

6

1 reference

14 September 2017

G Carter

7

1 reference

14 September 2017

B Johnson

8

1 reference

14 September 2017

K Rasmussen

9

1 reference

14 September 2017

L M Rorick-Kehn

10

1 reference

14 September 2017

language of work or name

English

0 references

publication date

12 May 2016

1 reference

Journal of Pharmacology and Experimental Therapeutics

14 September 2017

published in

1 reference

14 September 2017

volume

358

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

71-82

1 reference

Psychostimulants in moderate to severe affective disorder: a systematic review of randomized controlled trials

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

A role for AMPA receptors in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Anhedonia revisited: is there a role for dopamine-targeting drugs for depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Restoring mood balance in depression: ketamine reverses deficit in dopamine-dependent synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Ketamine-like effects of a combination of olanzapine and fluoxetine on AMPA and NMDA receptor-mediated transmission in the medial prefrontal cortex of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

The role of dopamine in the mechanism of action of antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Signaling pathways underlying the rapid antidepressant actions of ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

mTOR activation is required for the antidepressant effects of mGluR₂/₃ blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Increased intracranial self-stimulation in rats after long-term administration of desipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--1. Identification and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Rapid microelectrode measurements and the origin and regulation of extracellular glutamate in rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Role of the ventral subiculum in stress integration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Mechanisms underlying ketamine-induced synaptic depression in rat hippocampus-medial prefrontal cortex pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

AMPA receptor mediates mGlu 2/3 receptor antagonist-induced dopamine release in the rat nucleus accumbens shell

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Brain region and dose effects of an olanzapine/fluoxetine combination on extracellular monoamine concentrations in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Interactive effects of subanesthetic ketamine and haloperidol in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Neural correlates of change in major depressive disorder anhedonia following open-label ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Enhancement of antidepressant potency by a potentiator of AMPA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Dopamine D2/D3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim test

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

The MCH1 receptor antagonist SNAP 94847 induces sensitivity to dopamine D2/D3 receptor agonists in rats and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Glutamate neurons within the midbrain dopamine regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Long-term deficits in stimulation-induced behaviors and self-stimulation after 6-hydroxydopamine administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Neurocircuitry of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Triple reuptake inhibitors ("broad spectrum" antidepressants).

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA/NMDA receptor density ratio in female Wistar-Kyoto rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Functional antagonists at the NMDA receptor complex exhibit antidepressant actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Does REM Sleep Deprivation Induce a Supersensitivity of Dopaminergic Receptors in the Rat Brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Targeting glial physiology and glutamate cycling in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

Effects of chronic antidepressant drug administration and electroconvulsive shock on activity of dopaminergic neurons in the ventral tegmentum

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1124%2FJPET.116.233627

21 January 2018

Identifiers

DOI

10.1124/JPET.116.233627

1 reference

14 September 2017

1 reference